title: Feasibility of Using Virtual Reality to Assess Nicotine Cue Reactivity During Treatment.
abstract: Cue reactivity assessments have been widely used to assess craving and attention to cues among cigarette smokers. Cue reactivity has the potential to offer insights into treatment decisions; however, the use of cue reactivity in treatment studies has been limited. This study assessed the feasibility of using a virtual reality-based cue reactivity assessment approach (VR-NCRAS) during treatment. In a clinical smoking cessation treatment study, 46 treatment-seeking nicotine-dependent adult smokers were assessed for cue reactivity at baseline, Week 4, and Week 10 of treatment. Measures of cue reactivity included subjective craving and attention to cues after exposure to two neutral and two smoking cue environments. Overall, feasibility of using VR-NCRAS was demonstrated and these findings support the use of the cue reactivity assessment during treatment, which can inform treatment decisions.
authors.affiliation: Univeristy of Houston, Graduate College of Social Work, Houston, TX, USA.
authors.forename: Eili
authors.initials: E
authors.lastname: Kaganoff
authors.affiliation: Univeristy of Houston, Graduate College of Social Work, Houston, TX, USA.
authors.forename: Patrick S
authors.initials: PS
authors.lastname: Bordnick
authors.affiliation: Univeristy of Houston, Graduate College of Social Work, Houston, TX, USA.
authors.forename: Brian Lee
authors.initials: BL
authors.lastname: Carter
keywords: craving; cue reactivity; nicotine; smoking; virtual reality
references.citation: Addict Behav. 2004 Dec;29(9):1889-94
references.pmid: 15530734
references.citation: Addiction. 2000 Aug;95 Suppl 2:S129-44
references.pmid: 11002908
references.citation: Addiction. 2005 Nov;100(11):1720-30
references.pmid: 16277632
references.citation: Cyberpsychol Behav. 2009 Aug;12(4):373-8
references.pmid: 19630582
references.citation: Cyberpsychol Behav. 2005 Oct;8(5):487-92
references.pmid: 16232041
references.citation: Psychopharmacology (Berl). 2003 Apr;166(4):343-50
references.pmid: 12601502
references.citation: Addiction. 2001 Aug;96(8):1161-74
references.pmid: 11487422
references.citation: Psychol Addict Behav. 2006 Dec;20(4):484-9
references.pmid: 17176184
references.citation: Nicotine Tob Res. 2009 Jul;11(7):823-6
references.pmid: 19477914
references.citation: J Subst Abuse Treat. 2009 Apr;36(3):235-43
references.pmid: 18715743
references.citation: J Consult Clin Psychol. 2004 Dec;72(6):1136-43
references.pmid: 15612859
references.citation: Am J Addict. 2008 Sep-Oct;17(5):436-40
references.pmid: 18770087
references.citation: J Consult Clin Psychol. 2000 Apr;68(2):233-40
references.pmid: 10780123
references.citation: J Abnorm Psychol. 1988 May;97(2):133-52
references.pmid: 3290304
references.citation: Int J Addict. 1990-1991;25(7A-8A):957-93
references.pmid: 2131326
references.citation: J Psychoactive Drugs. 2009 Jun;41(2):105-12
references.pmid: 19705672
references.citation: Psychopharmacology (Berl). 2001 Apr;155(1):27-34
references.pmid: 11374333
references.citation: Addiction. 1999 Mar;94(3):327-40
references.pmid: 10605857
references.citation: Addict Behav. 2010 Feb;35(2):164-7
references.pmid: 19836144
references.citation: Addict Behav. 2007 Dec;32(12):2888-99
references.pmid: 17537583
references.citation: Addict Behav. 2008 Jun;33(6):743-56
references.pmid: 18282663
references.citation: Appl Psychophysiol Biofeedback. 2005 Sep;30(3):187-93
references.pmid: 16167184